4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001193125-25-297207
Options or other derivatives
- SVP, FINANCE AND ACCOUNTING acquired 231,700 shares (grant or award)
- SVP, FINANCE AND ACCOUNTING returned 100,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Brennan Kevin M. · SVP, FINANCE AND ACCOUNTING
Table II: Derivative
7 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +131,700 | 131,700 | D |
| 2025-11-21 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −55,000 | 0 | D |
| 2025-11-21 | Grant or award : show line 3 in the form Stock Option (right to buy) | +55,000 | 55,000 | D |
| 2025-11-21 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −25,000 | 0 | D |
| 2025-11-21 | Grant or award : show line 5 in the form Stock Option (right to buy) | +25,000 | 25,000 | D |
| 2025-11-21 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −20,000 | 0 | D |
| 2025-11-21 | Grant or award : show line 7 in the form Stock Option (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X05/ownership.xml…